Tour de France doping tests spark controversy: 'Inhumane' or 'necessary'?

Early morning doping tests at the Tour de France have ignited a debate within the cycling world, with riders expressing frustration over disrupted sleep and anti-doping officials defending the practice as crucial for combating performance-enhancing drugs.

“

Testing at 2 a.m. is one of the very effective ways to prevent microdosing of peptides (EPO, hGH) and testosterone. If the UCI had tested us at 2 a.m. in 2001? We would all have been suspended and we would have saved the sport 25 years of drama.

Former professional cyclist and team manager Jonathan Vaughters has become a vocal proponent of these unannounced tests, which have seen riders woken in the early hours for sample collection. Vaughters argues that such measures are essential for detecting substances like EPO and human growth hormone, which can be quickly eliminated from the body. He believes that if similar testing had been in place during his career, widespread doping scandals could have been averted much earlier.

His stance carries significant weight due to his personal history with doping; Vaughters himself admitted to using banned substances during his career and later testified against Lance Armstrong. He now manages the EF Education-EasyPost team, positioning himself as a champion of clean racing.

“

The visit cost me about 40 minutes of sleep before a mountain stage.

However, the practice has drawn criticism from prominent riders. Jonas Vingegaard, who was tested at 2 a.m. before a mountain stage where he later crashed and broke his collarbone, stated the disruption cost him valuable sleep. Tadej Pogačar, tested at 5 a.m., reported sleeping only four hours. Stage winner Remco Evenepoel labeled the procedure "inhumane."

“

It's inhumane.

The International Testing Agency (ITA) acknowledged that nocturnal testing can interfere with riders' rest but maintained that "effective testing must, in limited and justified circumstances, take place outside of daytime hours." The agency highlighted the challenge of microdosing substances like EPO and hGH, which necessitates testing outside predictable schedules to prevent athletes from evading detection.

“

We are aware that nocturnal testing can interfere with riders' rest and recovery. However, effective testing must, in limited and justified circumstances, take place outside of daytime hours.